IGM Biosciences' GAAP loss for 9M 2021 was $114.522 million, doubling from $56.733 million in the previous year.
IGM Biosciences' GAAP loss for 9M 2021 was $114.522 million, doubling from $56.733 million in the previous year.
Financial results
IGM Biosciences' GAAP loss for 9M 2021 was $114.522 million, doubling from $56.733 million in the previous year. Source: 
igmbio.gcs-web.com
igmbio.gcs-web.com
English (US) 